Further studies with the aid of pretreatment with interferon alpha [38], simultaneous administration of CpG DNA [19,39], or targeting MYCN or MDA5 may be helpful in augmenting the poly(I:C) sensitivity and NB immunotherapy. The gene discussed is MYCN; the disease is neuroblastoma.